Knowledge Center
Article / Jan 01, 2011
What is Special About Inhalation APIs?
Source:
Drug Development and Delivery, January 2011
What is Special About Inhalation APIs? Drug Development Executive: Carla Vozone, Director of Business Development for Hovione's Generics Business Unit, discusses what makes Hovione unique in API supply for inhalation, its supportive technologies, and approach to the market.
Related links
Also in the Knowledge Center
/ Nov 12, 2017
Spray Dried Composite Particles: Formulation and Process Parameters, Effect of two API Concentrations and Stability Assessment
Read more
Scientific Article
/ Nov 12, 2017
Paddle Over Disk as a Dissolution Test for Orally Inhaled Fluticasone Propionate
Read more
Scientific Article
/ Nov 12, 2017
In vitro - in vivo correlations of carbamazepine nano-dispersions for application in formulation development
Read more
Scientific Article